Background illustration for clinical trials search

Paid Clinical Trials Atlanta

Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Atlanta GA, Charlotte NC, Matthews NC, Huntersville NC,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase 3, Recruiting

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

for
Breast Cancer, Ovarian Cancer
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 25+

Code: NCT06760507

Recruiting

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia
Location: Atlanta GA, Seneca SC, Easley SC, Greenville SC,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18 - 39

Code: NCT03150693

Phase 3, Recruiting

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Atlanta GA, Homewood AL, Tampa FL, Indianapolis IN,
Sponsor: Oncolytics Biotech

Sex: All

Age: 18+

Code: NCT07446322

Phase 2, Recruiting

MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

for
Malignant Testicular Germ Cell Tumor
Location: Atlanta GA, Birmingham AL, New Brunswick NJ, Toronto,
Sponsor: University of Southern California

Sex: Male

Age: 18+

Code: NCT06060873

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Atlanta GA, Winston-Salem NC, Cincinnati OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03739814

Phase 2, Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

for
Cervical Carcinoma, Human Papillomavirus Infection
Location: Atlanta GA, Birmingham AL, Chapel Hill NC,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 25+

Code: NCT07281430

Recruiting

Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

for
Retroperitoneal Liposarcoma
Location: Atlanta GA, Columbus OH, Houston TX, Toronto
Sponsor: Australia and New Zealand Sarcoma Association

Sex: All

Age: 18+

Code: NCT07377747

Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

for
Multiple Myeloma (MM)
Location: Atlanta GA, Louisville KY, Durham NC, Baltimore MD,
Sponsor: C4 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07280013

Phase 1, Recruiting

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

for
Glioblastoma
Location: Atlanta GA, Orlando FL, Greenville NC, Columbus OH,
Sponsor: GT Medical Technologies, Inc.

Sex: All

Age: 18+

Code: NCT07195591

Phase 3, Recruiting

Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

for
Low Grade Upper Tract Urothelial Carcinoma
Location: Atlanta GA, Nashville TN, Mt. Pleasant SC,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT07265947

Phase 2, Recruiting

Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial

for
Advanced Acral Melanoma, Advanced Cutaneous Melanoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07155317

Phase 2, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Atlanta GA, Nashville TN, Savannah GA, Jacksonville FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase 3, Recruiting

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

for
Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer,
Location: Atlanta GA, Milwaukee WI, Lebanon NH, Honolulu HI
Sponsor: OncoTherapy Science, Inc.

Sex: All

Age: 18+

Code: NCT02926690

Phase 1, Recruiting

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

for
Multiple Myeloma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07101445

Recruiting

Clinical Pre-screening Protocol for Ovarian Cancer

for
Ovarian Cancer
Location: Atlanta GA, Tampa FL, New York NY, Oklahoma City OK,
Sponsor: Allarity Therapeutics

Sex: Female

Age: 18+

Code: NCT03877796

Recruiting

Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya

for
Breast Carcinoma
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT07764796

Recruiting

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-Resistant Prostate Cancer
Location: Atlanta GA, Nashville TN, Myrtle Beach SC, Durham NC,
Sponsor: Kyntra Bio

Sex: Male

Age: 18+

Code: NCT06842498

Phase 2, Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: Atlanta GA, Nashville TN, Durham NC, Fairfax VA,
Sponsor: EvolveImmune United, Inc

Sex: All

Age: 18+

Code: NCT07217171

Phase 1, Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Atlanta GA, Greenville SC, New Orleans LA, Columbus OH,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07080242

Phase 1, Recruiting